Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

665 ARTÍCULOS , VIENDO DEL 646 AL 660

New Perspectives of Taxifolin in Neurodegenerative Diseases

Yang R, Yang X, Zhang F.

Curr Neuropharmacol. 2023;21(10):2097-2109. doi: 10.2174/1570159X21666230203101107.

The Impact of Neurotransmitters on the Neurobiology of Neurodegenerative Diseases

Davis SE, Cirincione AB, Jimenez-Torres AC, Zhu J.

Int J Mol Sci. 2023 Oct 19;24(20):15340. doi: 10.3390/ijms242015340.

The function of astrocytes and their role in neurological diseases

Yuan WQ, Huang WP, Jiang YC, Xu H, Duan CS, Chen NH, Liu YJ, Fu XM.

Eur J Neurosci. 2023 Nov;58(9):3932-3961. doi: 10.1111/ejn.16160. Epub 2023 Oct 13.

lncRNA NEAT1: Key player in neurodegenerative diseases

Li K, Wang Z.

Ageing Res Rev. 2023 Apr;86:101878. doi: 10.1016/j.arr.2023.101878. Epub 2023 Feb 3.

Neurodegeneration and epigenetics: A review

Ghosh P, Saadat A.

Neurologia (Engl Ed). 2023 Jul-Aug;38(6):e62-e68. doi: 10.1016/j.nrleng.2023.05.001.

Systematic review of pharmacological interventions for people with Lewy body dementia

Watts KE, Storr NJ, Barr PG, Rajkumar AP.

Aging Ment Health. 2023 Feb;27(2):203-216. doi: 10.1080/13607863.2022.2032601. Epub 2022 Feb 2.

Unmet needs in the diagnosis and treatment of Parkinson's disease psychosis and dementia-related psychosis

Sabbagh M, Small GW, Isaacson SH, Torres-Yaghi Y, Pagan F, Pahwa R.

Int J Psychiatry Clin Pract. 2023 Mar;27(1):69-81. doi: 10.1080/13651501.2022.2058406. Epub 2022 May 14.

The regulatory mechanism and therapeutic potential of transcription factor EB in neurodegenerative diseases

Jiao F, Zhou B, Meng L.

CNS Neurosci Ther. 2023 Jan;29(1):37-59. doi: 10.1111/cns.13985. Epub 2022 Oct 2.

Incretin and insulin signaling as novel therapeutic targets for Alzheimer's and Parkinson's disease

Nowell J, Blunt E, Edison P.

Mol Psychiatry. 2023 Jan;28(1):217-229. doi: 10.1038/s41380-022-01792-4. Epub 2022 Oct 18.

Challenges in diagnosis and management of delirium in Lewy body disease

Richardson S, Lawson RA, Price A, Taylor JP.

Acta Psychiatr Scand. 2023 May;147(5):475-480. doi: 10.1111/acps.13514. Epub 2022 Nov 4.

Imaging Biomarkers for Central Nervous System Drug Development and Future Clinical Utility: Lessons from Neurodegenerative Disorders

Seibyl JP.

J Nucl Med. 2023 Jan;64(1):12-19. doi: 10.2967/jnumed.122.264773. Epub 2022 Oct 27.

The emerging relationship between vitamin K and neurodegenerative diseases: a review of current evidence

Emekli-Alturfan E, Alturfan AA.

Mol Biol Rep. 2023 Jan;50(1):815-828. doi: 10.1007/s11033-022-07925-w. Epub 2022 Nov 3.

Surface-modified lipid nanocarriers for crossing the blood-brain barrier (BBB): A current overview of active targeting in brain diseases

Teixeira MI, Lopes CM, Amaral MH, Costa PC.

Colloids Surf B Biointerfaces. 2023 Jan;221:112999. doi: 10.1016/j.colsurfb.2022.112999. Epub 2022 Nov 2.

Regenerative medicine improve neurodegenerative diseases

Ashraf SS, Hosseinpour Sarmadi V, Larijani G, Naderi Garahgheshlagh S, Ramezani S, Moghadamifar S, Mohebi SL, Brouki Milan P, Haramshahi SMA, Ahmadirad N, Amini N.

Cell Tissue Bank. 2023 Sep;24(3):639-650. doi: 10.1007/s10561-022-10062-0. Epub 2022 Dec 17.

Molecular Hydrogen: an Emerging Therapeutic Medical Gas for Brain Disorders

Wu C, Zou P, Feng S, Zhu L, Li F, Liu TC, Duan R, Yang L.

Mol Neurobiol. 2023 Apr;60(4):1749-1765. doi: 10.1007/s12035-022-03175-w. Epub 2022 Dec 26.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias